The Avextra team (L-R): co-CEO Bernhard Babel, COO Neil Smith, co-CEO David Reckeweg-Lecompte and CSO Marla Luther
March 15, 2023 10:14 AM EDT
Financing
R&D
Manufacturing

Ger­man cannabis med­i­cine man­u­fac­tur­er lands $17M+ in fund­ing

Tyler Patchen

News Reporter

The Ger­man-based cannabis med­i­cine pro­duc­er Avex­tra has reeled in some new funds while al­so look­ing to ex­pand its reach with­in Eu­rope.

Avex­tra an­nounced Wednes­day that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times